1-20 of 24
Authors: Natalia Stepien
Journal Article
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens Open Access
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 811–827, https://doi.org/10.1093/neuonc/noae228
Published: 18 November 2024
Journal Article
Distinct relapse pattern across molecular ependymoma types Get access
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 267–276, https://doi.org/10.1093/neuonc/noae166
Published: 22 August 2024
Journal Article
ATRT-12. EXPLORING FGFR INHIBITION AND COMBINATION THERAPIES FOR ATYPICAL TERATOID/RHABDOID TUMORS Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.012
Published: 18 June 2024
Journal Article
BIOM-09. TOWARDS CLINICAL IMPLEMENTATION OF LIQUID BIOPSY ANALYSIS FOR PAEDIATRIC BRAIN TUMOUR PATIENTS – A PAN-EUROPEAN EFFORT FOR STANDARDIZATION Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.028
Published: 18 June 2024
Journal Article
ETMR-27. ANTI-ANGIOGENIC METRONOMIC THERAPY OF RARE TUMOURS OF THE CENTRAL NERVOUS SYSTEM Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.197
Published: 18 June 2024
Journal Article
EPEN-12. EZHIP IMPACTS CELLULAR DIFFERENTIATION IN POSTERIOR FOSSA GROUP A EPENDYMOMA Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.214
Published: 18 June 2024
Journal Article
EPEN-10. INDUCING A SENESCENCE PHENOTYPE BY BROMODOMAIN INHIBITION IN HIGH-RISK EPENDYMOMA Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.212
Published: 18 June 2024
Journal Article
PATH-12. ROBUST CELL-FREE DNA METHYLATION-BASED CLASSIFICATION OF PEDIATRIC BRAIN TUMOR LIQUID BIOPSIES Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.715
Published: 18 June 2024
Journal Article
CP-07. FEASIBILITY, TOLERABILITY AND FIRST EXPERIENCE OF INTRACYSTIC TREATMENT WITH PEGINTERFERON ALFA-2A IN PATIENTS WITH CYSTIC CRANIOPHARYNGIOMA Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.045
Published: 18 June 2024
Journal Article
PATH-08. PRE-OPERATIVE TUMOUR CLASSIFICATION USING NANOPORE SEQUENCING OF CEREBROSPINAL FLUID Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.711
Published: 18 June 2024
Journal Article
MDB-36. 22-HDOHE, A PREDICTIVE MARKER IN CSF OF PATIENTS WITH RECURRENT MEDULLOBLASTOMA TREATED WITH MEMMAT Open Access
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.485
Published: 18 June 2024
Journal Article
DDDR-17. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v108–v109, https://doi.org/10.1093/neuonc/noad179.0411
Published: 10 November 2023
Journal Article
TRLS-08. EXPERIENCE WITH THE SELECTIVE FIBROBLAST GROWTH FACTOR INHIBITOR ERDAFITINIB IN THREE PEDIATRIC PATIENTS WITH CNS TUMORS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i80–i81, https://doi.org/10.1093/neuonc/noad073.311
Published: 12 June 2023
Journal Article
ATRT-07. CLINICAL APPLICABILITY OF C19MC MIRNA DETECTION IN LIQUID BIOPSIES OF ETMR PATIENTS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i2, https://doi.org/10.1093/neuonc/noad073.007
Published: 12 June 2023
Journal Article
HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS Open Access
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i43–i44, https://doi.org/10.1093/neuonc/noad073.168
Published: 12 June 2023
Journal Article
DDDR-22. TRANSLATION OF THE PDGFRA/KIT INHIBITOR AVAPRITINIB FOR PEDIATRIC HIGH-GRADE GLIOMA Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii103, https://doi.org/10.1093/neuonc/noac209.387
Published: 14 November 2022
Journal Article
DIPG-60. Avapritinib for targeting PDGFRA in H3K27M – mutated diffuse midline glioma Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i32, https://doi.org/10.1093/neuonc/noac079.117
Published: 03 June 2022
Journal Article
DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i34–i35, https://doi.org/10.1093/neuonc/noac079.126
Published: 03 June 2022
Journal Article
PATH-09. Liquid biopsy of cerebrospinal fluid enables detecting and monitoring ofMYC/MYCN amplification in pediatric CNS malignancies Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i160, https://doi.org/10.1093/neuonc/noac079.593
Published: 03 June 2022
Journal Article
HGG-50. Specific sensitivity of pediatric high-grade glioma with ATRX inactivation to PARP inhibitor combinations Open Access
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i73, https://doi.org/10.1093/neuonc/noac079.265
Published: 03 June 2022
